To own Hagerty, you need to believe the specialty auto insurer can keep turning strong written premium growth into durable earnings, even as reported revenue and net income remain bumpy through the Markel fronting transition. The latest quarter showed 18% written premium growth and an upgraded profit outlook, which supports that thesis on the operating side.
The near term catalyst is clear. Management is guiding to higher 2026 GAAP net income and adjusted EBITDA, helped by favorable loss trends and underwriting economics. The biggest risk is that accounting drag, episodic Marketplace revenue and softer profit, such as Q3’s lower net income versus last year, keep reported results uneven.
The guidance hike on GAAP net income to US$48 million to US$60 million and adjusted EBITDA to US$305 million to US$315 million is the announcement that ties everything together. It connects the Markel structure, underwriting, and State Farm Classic+ rollout into a clearer earnings story that investors can actually track across quarters.
That said, the catalyst cuts both ways. Record Broad Arrow auction sales and strong member growth support fee and premium potential, yet management still describes Marketplace revenue as chunky. If auction activity normalises while the Markel related accounting effects and prior one off items keep distorting GAAP, sentiment could pivot quickly if expectations get ahead of delivered profit.
Analysts’ base case for Hagerty ties together modest top line expansion with a sharp step up in profitability. Hagerty’s narrative projects US$1.6b revenue and US$312.4 million earnings by 2029, which assumes 4.3% yearly revenue growth and requires earnings to rise by roughly 20x from US$16.0 million today.
Uncover why Hagerty's fair value indicates a 15% potential downside to its current price, which leaves little room for error.
The big swing factor in the more optimistic Hagerty narrative is earnings power. The most bullish analysts were pencilling in US$1.7b revenue and US$392.9 million earnings by 2029, far above the consensus US$1.6b and US$312.4 million. Those views were set before this earnings beat, so you should expect opinions to evolve and differ widely.
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
Hagerty may sit at the center of your watchlist today, but your broader portfolio can benefit from comparing this specialty insurer to other opportunities across different balance sheet strengths, income profiles, and growth drivers.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com